1. Home
  2. PBM vs LCFY Comparison

PBM vs LCFY Comparison

Compare PBM & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBM
  • LCFY
  • Stock Information
  • Founded
  • PBM 1994
  • LCFY 2009
  • Country
  • PBM Canada
  • LCFY Australia
  • Employees
  • PBM N/A
  • LCFY N/A
  • Industry
  • PBM
  • LCFY
  • Sector
  • PBM
  • LCFY
  • Exchange
  • PBM NYSE
  • LCFY Nasdaq
  • Market Cap
  • PBM 5.3M
  • LCFY 9.9M
  • IPO Year
  • PBM N/A
  • LCFY 2022
  • Fundamental
  • Price
  • PBM $0.76
  • LCFY $5.25
  • Analyst Decision
  • PBM
  • LCFY
  • Analyst Count
  • PBM 0
  • LCFY 0
  • Target Price
  • PBM N/A
  • LCFY N/A
  • AVG Volume (30 Days)
  • PBM 485.7K
  • LCFY 14.0K
  • Earning Date
  • PBM 04-07-2025
  • LCFY 04-30-2025
  • Dividend Yield
  • PBM N/A
  • LCFY N/A
  • EPS Growth
  • PBM N/A
  • LCFY N/A
  • EPS
  • PBM N/A
  • LCFY N/A
  • Revenue
  • PBM N/A
  • LCFY $2,668,385.00
  • Revenue This Year
  • PBM N/A
  • LCFY N/A
  • Revenue Next Year
  • PBM N/A
  • LCFY N/A
  • P/E Ratio
  • PBM N/A
  • LCFY N/A
  • Revenue Growth
  • PBM N/A
  • LCFY N/A
  • 52 Week Low
  • PBM $0.75
  • LCFY $2.20
  • 52 Week High
  • PBM $140.25
  • LCFY $11.23
  • Technical
  • Relative Strength Index (RSI)
  • PBM 26.30
  • LCFY 31.04
  • Support Level
  • PBM $0.88
  • LCFY $5.08
  • Resistance Level
  • PBM $0.94
  • LCFY $6.52
  • Average True Range (ATR)
  • PBM 0.09
  • LCFY 0.58
  • MACD
  • PBM -0.01
  • LCFY -0.12
  • Stochastic Oscillator
  • PBM 1.49
  • LCFY 5.91

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About LCFY Locafy Limited

Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.

Share on Social Networks: